Literature DB >> 32707161

Dupilumab use in recalcitrant allergic fungal rhinosinusitis.

Rachelle M Lo1, Anne Y Liu2, Tulio A Valdez3, Yael Gernez4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32707161     DOI： 10.1016/j.anai.2020.07.014

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  3 in total

1.  Successful Use of Dupilumab as a Salvage Therapy for Recalcitrant Allergic Fungal Rhinosinusitis: A Case Report.

Authors:  Revan A Mujahed; Osama A Marglani; Lama S Maksood; Talah A Felemban
Journal:  Cureus       Date:  2022-03-12

2.  Dupilumab: An emerging therapy in allergic fungal rhinosinusitis.

Authors:  Adeeb A Bulkhi; Ahmad A Mirza; Abdullah J Aburiziza; Osama A Marglani
Journal:  World Allergy Organ J       Date:  2022-03-30       Impact factor: 5.516

Review 3.  Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil.

Authors:  Wilma T Anselmo-Lima; Edwin Tamashiro; Fabrizio R Romano; Marcel M Miyake; Renato Roithmann; Eduardo M Kosugi; Márcio Nakanishi; Marco A Fornazieri; Thiago F P Bezerra; João F Mello; Marcus M Lessa; Richard L Voegels; Otávio B Piltcher; Eulalia Sakano; Fabiana C P Valera
Journal:  Braz J Otorhinolaryngol       Date:  2021-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.